All News about Xenon Pharmaceuticals Inc
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Xenon Pharmaceuticals: Q1 Earnings Insights
May 09, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Where Xenon Pharmaceuticals Stands With Analysts
April 25, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_133.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Xenon Pharmaceuticals Earnings Preview
February 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1563.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Xenon Pharmaceuticals
January 31, 2023
Via Benzinga
Analyst Ratings for Xenon Pharmaceuticals
December 14, 2022
Via Benzinga
Xenon Pharmaceuticals Earnings Perspective: Return On Capital Employed
December 06, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/25/xene.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
Xenon Pharmaceuticals to Present at the Stifel 2023 CNS Days
March 22, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2018/12/Stock-DrugDesigner-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/02/shutterstock_1701548905.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2023
January 09, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
![](https://ml.globenewswire.com/media/8d6d71bc-62fa-4fff-a060-f7660b8738b9/small/logo-icon-teal-500px-jpg.jpg)
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.